2023 Q4 Form 10-Q Financial Statement

#000149315223037327 Filed on October 16, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q2 2022 Q2

Balance Sheet

Concept 2023 Q4 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $112.0K $1.437M
YoY Change -92.21% 183.7%
Cash & Equivalents $112.0K $1.493M
Short-Term Investments
Other Short-Term Assets $176.2K $137.0K
YoY Change 28.6% 128.37%
Inventory
Prepaid Expenses
Receivables $1.450K $1.362K
Other Receivables $0.00 $0.00
Total Short-Term Assets $289.7K $1.575M
YoY Change -81.61% 168.59%
LONG-TERM ASSETS
Property, Plant & Equipment $28.20K $541.0K
YoY Change -94.79%
Goodwill
YoY Change
Intangibles $450.4K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $478.6K $541.0K
YoY Change -11.53%
TOTAL ASSETS
Total Short-Term Assets $289.7K $1.575M
Total Long-Term Assets $478.6K $541.0K
Total Assets $768.3K $2.116M
YoY Change -63.7% 260.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $603.9K $657.4K
YoY Change -8.15% 182.36%
Accrued Expenses
YoY Change
Deferred Revenue $55.84K $11.29K
YoY Change 394.54%
Short-Term Debt $403.5K $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.089M $716.4K
YoY Change 51.98% 168.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.089M $716.4K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.089M $716.4K
YoY Change 51.98% 168.66%
SHAREHOLDERS EQUITY
Retained Earnings -$13.73M -$10.12M
YoY Change 35.69%
Common Stock $32.43K $28.37K
YoY Change 14.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$320.5K $1.400M
YoY Change
Total Liabilities & Shareholders Equity $768.3K $2.116M
YoY Change -63.7% 260.83%

Cashflow Statement

Concept 2023 Q4 2023 Q2 2022 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000823546
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
usd
CY2023Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2023Q2 us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
usd
CY2022Q2 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2023Q2 us-gaap Payments For Software
PaymentsForSoftware
usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2022Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2022Q2 us-gaap Interest Paid
InterestPaid
usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
033-17773-NY
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
ROCKETFUEL BLOCKCHAIN, INC.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-1188745
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
201 Spear Street
CY2023Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1100
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94105
CY2023Q2 dei City Area Code
CityAreaCode
(424)
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
256-8560
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q2 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
35604890 shares
CY2023Q2 us-gaap Cash
Cash
112004 usd
CY2023Q1 us-gaap Cash
Cash
421566 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1450 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
176212 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
143870 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
289666 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
565436 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
827664 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
655333 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
450398 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
622729 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4721 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10814 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28202 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28202 usd
CY2023Q2 us-gaap Assets
Assets
768266 usd
CY2023Q1 us-gaap Assets
Assets
1216367 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
603878 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
680460 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
17290 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
0 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
403493 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
276667 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
55844 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
57231 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1088777 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1039991 usd
CY2023Q2 us-gaap Liabilities
Liabilities
1088777 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1039991 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32427446 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32427446 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32427446 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32427446 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
32428 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
32428 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13341407 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13055831 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13733446 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12950983 usd
CY2023Q2 RKFL Common Shares To Be Issued Related Party
CommonSharesToBeIssuedRelatedParty
39100 usd
CY2023Q1 RKFL Common Shares To Be Issued Related Party
CommonSharesToBeIssuedRelatedParty
39100 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-320511 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
176376 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
768266 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1216367 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
235459 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8132 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
258965 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
998081 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1237954 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
998081 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1496919 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-762622 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1488787 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
19841 usd
CY2022Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
540059 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19841 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
540059 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-782463 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-948728 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-782463 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-948728 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32427446 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32427446 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31205000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31205000 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2597245 usd
CY2022Q2 us-gaap Stock Granted During Period Value Sharebased Compensation Forfeited
StockGrantedDuringPeriodValueSharebasedCompensationForfeited
540059 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
291682 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-948728 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1399840 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
176376 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
176376 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
285576 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-782463 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-320511 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-320511 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-782463 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-948728 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
172331 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
87081 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
285576 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
291382 usd
CY2023Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2470 usd
CY2022Q2 us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
549059 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1450 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2113 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
32343 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
68707 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-51090 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
170230 usd
CY2023Q2 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-25562 usd
CY2022Q2 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
36402 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-17371 usd
CY2023Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1387 usd
CY2022Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3781 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-416547 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-974067 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5393 usd
CY2022Q2 us-gaap Payments For Software
PaymentsForSoftware
162488 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-167881 usd
CY2023Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
125000 usd
CY2023Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
18015 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
106985 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-309562 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1141948 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
421566 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2634794 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
112004 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1492846 usd
CY2023Q2 us-gaap Interest Paid
InterestPaid
1448 usd
CY2023Q2 us-gaap Debt Instrument Convertible Terms Of Conversion Feature
DebtInstrumentConvertibleTermsOfConversionFeature
We then computed the present value of the bond components of the Note assuming (1) conversion upon an event of default and (2) repayment of the Note in full in cash, in each case using a 35% discount factor for a term of 0.86 years, and weighted the resulting present values based on assumed probabilities of 85% for conversion upon an event of default, 10% for repayment in full and 5% for complete default. We then applied a 6.4% issuance negotiation discount to the resulting probability-weighted bond value. The 35% discount rate was calculated by adding the observed issuance spread of 29.6% to the risk-free rate of 5.4% per annum for the remaining term of 0.86 years. We determined that the amount of derivative liability for the fiscal quarter ended June 30, 2023, as well as the change from the previous quarter, was not material.
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zlg7HKGD9pZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zFfHuip5E5S2">Use of Accounting Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and judgments, which are evaluated on an ongoing basis, and that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13911036 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13401272 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13911036 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13401272 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-782463 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
285576 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-416547 usd
CY2023Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
150000 usd
CY2023Q2 RKFL Accumulated Depreciation Depletion And Amortization Intangible Assets And Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationIntangibleAssetsAndPropertyPlantAndEquipment
827664 usd
CY2023Q1 RKFL Accumulated Depreciation Depletion And Amortization Intangible Assets And Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationIntangibleAssetsAndPropertyPlantAndEquipment
666146 usd
CY2023Q2 RKFL Intangible Assets And Property Plant And Equipment Net
IntangibleAssetsAndPropertyPlantAndEquipmentNet
478600 usd
CY2023Q1 RKFL Intangible Assets And Property Plant And Equipment Net
IntangibleAssetsAndPropertyPlantAndEquipmentNet
650931 usd
CY2023Q2 us-gaap Depreciation
Depreciation
172331 usd
CY2022Q2 us-gaap Depreciation
Depreciation
172331 usd
CY2023Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
87081 usd
CY2022Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
87081 usd
CY2023Q2 us-gaap Legal Fees
LegalFees
6663 usd
CY2022Q2 us-gaap Legal Fees
LegalFees
58058 usd
CY2023Q2 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
25562 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
25633 usd
CY2023Q2 us-gaap Revenues
Revenues
235459 usd
CY2022Q2 us-gaap Revenues
Revenues
8132 usd
CY2023Q2 us-gaap Deferred Revenue
DeferredRevenue
55844 usd
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
57231 usd
CY2023Q2 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
64583.35 usd
CY2023Q1 us-gaap Debt Instrument Description
DebtInstrumentDescription
(i) the principal amount thereof shall equal the amount of salary deferred; (ii) the Notes shall mature on October 1, 2023; (iii) the Notes shall bear interest at a rate of 10% per annum; (iv) if not repaid by December 31, 2023, there shall be a 50% premium, and if the Notes are not repaid by their maturity, there shall a 100% premium
CY2023Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
150000 usd
CY2023Q2 us-gaap Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
Upon the occurrence and during the continuation of any Event of Default, the Note shall become immediately due and payable and we will be obligated to pay to the Lender, in full satisfaction of our obligations, an amount equal to 150% times the sum of (w) the then outstanding principal amount of the Note plus (x) accrued and unpaid interest on the unpaid principal amount of the Note to the date of payment plus (y) default interest, if any, at the rate of 22% per annum on the amounts referred to in clauses (w) and/or (x) plus (z) any amounts owed to the Holder pursuant to the conversion rights referred to below
CY2023Q2 us-gaap Debt Instrument Convertible Conversion Ratio1
DebtInstrumentConvertibleConversionRatio1
0.61 pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
On May 10, 2022, the Board has approved a plan to increase the number of shares to 8,000,000 for 2018 plan
CY2020Q4 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
5100000 usd
CY2023Q1 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
750000 usd
CY2023Q1 us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
525000 usd

Files In Submission

Name View Source Status
0001493152-23-037327-index-headers.html Edgar Link pending
0001493152-23-037327-index.html Edgar Link pending
0001493152-23-037327.txt Edgar Link pending
0001493152-23-037327-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rkfl-20230630.xsd Edgar Link pending
Show.js Edgar Link pending
rkfl-20230630_cal.xml Edgar Link unprocessable
rkfl-20230630_lab.xml Edgar Link unprocessable
rkfl-20230630_def.xml Edgar Link unprocessable
rkfl-20230630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed